PE20140199A1 - 6-amino-nicotinamidas sustituidas como moduladores de kcnq2/3 - Google Patents
6-amino-nicotinamidas sustituidas como moduladores de kcnq2/3Info
- Publication number
- PE20140199A1 PE20140199A1 PE2013000887A PE2013000887A PE20140199A1 PE 20140199 A1 PE20140199 A1 PE 20140199A1 PE 2013000887 A PE2013000887 A PE 2013000887A PE 2013000887 A PE2013000887 A PE 2013000887A PE 20140199 A1 PE20140199 A1 PE 20140199A1
- Authority
- PE
- Peru
- Prior art keywords
- methyl
- kcnq2
- modulators
- amino
- aliphatic residue
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
- C07D213/82—Amides; Imides in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Urology & Nephrology (AREA)
- Rheumatology (AREA)
- Addiction (AREA)
- Hospice & Palliative Care (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
REFERIDA A UN DERIVADO DE 6-AMINO-NICOTINAMIDA DE FORMULA (I), DONDE R1 ES UN RESIDUO ALIFATICO C1-C10, UN RESIDUO CILOALIFATICO C3-C10, ENTRE OTROS; R2 ES F, Cl, Br, CN, CF3, ENTRE OTROS; R4 ES UN RESIDUO ALIFATICO C1-C10, UN RESIDUO CILOALIFATICO C3-C10, ENTRE OTROS; R5 ES H O UN RESIDUO ALIFATICO C1-C10; R6 ES UN RESIDUO ALIFATICO C2-C6, UN RESIDUO O-C1-ALIFATICO, ENTRE OTROS. SON COMPUESTOS PREFERIDOS: N- (3,5-DIFLUORO-FENILO)-METILO-2-ETILOSULFANILO-4-METILO-6 MORFOLINO-4-IL-PIRIDINA-3-AMIDA DE ACIDO CARBOXILICO, 2-ETILOSULFANILO-N-3-FLUOROFENILO-METILO-4-METILO-6-MORFOLINO-4-IL-PIRIDINA-3-AMIDA DE ACIDO CARBOXILICO, N-3,5-DIFLUORO-FENILO-METILO-2-METOXI-4-METILO-6-MORFOLINO-4-IL-PIRIDINA-3-AMIDA DE ACIDO CARBOXILICO, ENTRE OTROS. DICHOS COMPUESTOS SON MODULADORES DEL CANAL KCNQ2/3 K+ Y SON UTILES EN EL TRATAMIENTO DEL DOLOR AGUDO, DOLOR CRONICO, DOLOR NEUROPATICO, ENTRE OTROS
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP10013811 | 2010-10-20 |
Publications (1)
Publication Number | Publication Date |
---|---|
PE20140199A1 true PE20140199A1 (es) | 2014-02-16 |
Family
ID=43447658
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE2013000887A PE20140199A1 (es) | 2010-10-20 | 2011-10-19 | 6-amino-nicotinamidas sustituidas como moduladores de kcnq2/3 |
Country Status (19)
Country | Link |
---|---|
US (1) | US8552200B2 (es) |
EP (2) | EP2630123B1 (es) |
JP (1) | JP5947307B2 (es) |
KR (1) | KR101820645B1 (es) |
CN (1) | CN103209962B (es) |
AR (1) | AR083477A1 (es) |
AU (1) | AU2011317855B2 (es) |
BR (1) | BR112013010957A2 (es) |
CA (1) | CA2815131C (es) |
CL (1) | CL2013001073A1 (es) |
CO (1) | CO6690805A2 (es) |
EA (1) | EA022582B1 (es) |
EC (1) | ECSP13012573A (es) |
ES (1) | ES2678899T3 (es) |
IL (1) | IL225762A (es) |
MX (1) | MX367623B (es) |
NZ (2) | NZ628871A (es) |
PE (1) | PE20140199A1 (es) |
WO (1) | WO2012052167A1 (es) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8354435B2 (en) | 2008-09-08 | 2013-01-15 | The Board Of Trustees Of The Leland Stanford Junior University | Modulators of aldehyde dehydrogenase activity and methods of use thereof |
US8389522B2 (en) | 2008-10-28 | 2013-03-05 | The Board Of Trustees Of The Leland Stanford Junior University | Modulators of aldehyde dehydrogenase and methods of use thereof |
US9168259B2 (en) | 2010-10-20 | 2015-10-27 | Grünenthal GmbH | Substituted 6-amino-nicotinamides as KCNQ2/3 modulators |
WO2012149106A1 (en) | 2011-04-29 | 2012-11-01 | The Board Of Trustees Of The Leland Stanford Junior University | Compositions and methods for increasing proliferation of adult salivary stem cells |
AU2013248638A1 (en) | 2012-04-18 | 2014-12-04 | Grünenthal GmbH | Substituted 4-aminobenzamides as KCNQ2/3 modulators |
SI2888233T1 (sl) * | 2012-04-18 | 2016-12-30 | Gruenenthal Gmbh | Substituirani 6-amino-nikotinamidi, ki nosijo skupino, ki vsebuje OH, kot modulatorji KCNQ2/3 |
EP2876106A4 (en) * | 2012-07-19 | 2016-03-30 | Nippon Soda Co | PYRIDINE COMPOUND AND AGRICULTURAL / HORTICULTURAL BACTERICIDE |
EP2906217A1 (en) * | 2012-10-11 | 2015-08-19 | Grünenthal GmbH | Treatment and/or prophylaxis of tspo mediated diseases and/or disorders |
JP2016508960A (ja) | 2012-11-28 | 2016-03-24 | グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング | Kcnq2/3モジュレーターとしての特定のカルボキサミド |
BR112015012420A8 (pt) * | 2012-11-28 | 2017-10-24 | Gruenenthal Gmbh | amino-arilcarboxamidas substituídas como moduladores de kcnq2/3 |
AU2013351551A1 (en) * | 2012-11-28 | 2015-07-16 | Grunenthal Gmbh | Heteroquinoline-3-carboxamides as KCNQ2/3 modulators |
US9248122B2 (en) | 2012-11-28 | 2016-02-02 | Grünenthal GmbH | Heteroquinoline-3-carboxamides as KCNQ2/3 modulators |
JO3377B1 (ar) | 2013-03-11 | 2019-03-13 | Takeda Pharmaceuticals Co | مشتقات بيريدينيل وبيريدينيل مندمج |
US9670162B2 (en) | 2013-03-14 | 2017-06-06 | The Board Of Trustees Of The Leland Stanford Junio | Mitochondrial aldehyde dehyrogenase-2 modulators and methods of use thereof |
WO2015098989A1 (ja) | 2013-12-25 | 2015-07-02 | Jcrファーマ株式会社 | 血液脳関門を通過する新規抗トランスフェリン受容体抗体 |
CN111407726A (zh) * | 2020-04-13 | 2020-07-14 | 牡丹江医学院 | 一种治疗口腔炎的药物制剂及其制备方法 |
CN112624966B (zh) * | 2020-12-25 | 2022-12-23 | 杭州澳赛诺生物科技有限公司 | 一种2-氨甲基-4-甲基-5-吡啶羧酸的合成方法 |
EP4074317A1 (en) | 2021-04-14 | 2022-10-19 | Bayer AG | Phosphorus derivatives as novel sos1 inhibitors |
WO2023018643A1 (en) | 2021-08-10 | 2023-02-16 | Abbvie Inc. | Nicotinamide ripk1 inhibitors |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2230392A1 (de) * | 1972-06-22 | 1974-01-31 | Cassella Farbwerke Mainkur Ag | Substituierte pyridinverbindungen und verfahren zu ihrer herstellung |
DE2513949A1 (de) * | 1975-03-29 | 1976-10-07 | Bayer Ag | Azofarbstoffe |
DK1303269T3 (da) * | 2000-06-29 | 2006-03-20 | Neurosearch As | 3-substituerede oxindolderivater og deres anvendelse som KCNQ-kaliumkanalmodulatorer |
EP1361879A1 (en) | 2001-02-20 | 2003-11-19 | Bristol-Myers Squibb Company | 2,4-disubstituted pyrimidine-5-carboxamide derivatives as kcnq potassium channel modulators |
US6855829B2 (en) | 2001-02-20 | 2005-02-15 | Bristol-Myers Squibb Company | 3-fluoro-2-oxindole modulators of KCNQ potassium channels and use thereof in treating migraine and mechanistically related disease |
GB0222495D0 (en) * | 2002-09-27 | 2002-11-06 | Glaxo Group Ltd | Compounds |
GB0402357D0 (en) * | 2004-02-03 | 2004-03-10 | Glaxo Group Ltd | Novel compounds |
GB0402355D0 (en) * | 2004-02-03 | 2004-03-10 | Glaxo Group Ltd | Novel compounds |
EP1861394A1 (en) * | 2005-03-03 | 2007-12-05 | H.Lundbeck A/S | Substituted pyridine derivatives |
UA93387C2 (ru) * | 2005-09-09 | 2011-02-10 | X. Луннбэк A/C | Производные пиримидина и их применение b качестве открывателей калиевых каналов kcnq |
DE102006049452A1 (de) | 2006-10-17 | 2008-05-08 | Grünenthal GmbH | Substituierte Tetrahydropyrolopiperazin-Verbindungen und deren Verwendung in Arzneimitteln |
DE102007044277A1 (de) * | 2007-09-17 | 2009-03-19 | Grünenthal GmbH | Substituierte Nicotinamid-Verbindungen und deren Verwendung in Arzneimitteln |
DK2350093T3 (da) | 2008-10-24 | 2012-11-12 | Gruenenthal Gmbh | Substituerede 4,5,6,7-tetrahydrothienopyridiner som KCNQ2/3-modulatorer til behandling af smerte, epilepsi og urininkontinens. |
WO2010094644A1 (en) * | 2009-02-17 | 2010-08-26 | Neurosearch A/S | Substituted pyridine derivatives and their medical use |
TWI475020B (zh) * | 2009-03-12 | 2015-03-01 | The substituted nicotine amide as a KCNQ2 / 3 modifier | |
TW201038565A (en) * | 2009-03-12 | 2010-11-01 | Gruenenthal Gmbh | Substituted 2-mercapto-3-aminopyridines as KCNQ2/3 modulators |
-
2011
- 2011-10-19 EA EA201300471A patent/EA022582B1/ru not_active IP Right Cessation
- 2011-10-19 CN CN201180050690.6A patent/CN103209962B/zh not_active Expired - Fee Related
- 2011-10-19 EP EP11778520.4A patent/EP2630123B1/en not_active Not-in-force
- 2011-10-19 BR BR112013010957A patent/BR112013010957A2/pt not_active IP Right Cessation
- 2011-10-19 CA CA2815131A patent/CA2815131C/en not_active Expired - Fee Related
- 2011-10-19 EP EP17200118.2A patent/EP3318556A1/en not_active Withdrawn
- 2011-10-19 WO PCT/EP2011/005265 patent/WO2012052167A1/en active Application Filing
- 2011-10-19 KR KR1020137012802A patent/KR101820645B1/ko active IP Right Grant
- 2011-10-19 MX MX2013004329A patent/MX367623B/es active IP Right Grant
- 2011-10-19 AU AU2011317855A patent/AU2011317855B2/en not_active Ceased
- 2011-10-19 JP JP2013534196A patent/JP5947307B2/ja not_active Expired - Fee Related
- 2011-10-19 NZ NZ628871A patent/NZ628871A/en not_active IP Right Cessation
- 2011-10-19 AR ARP110103861A patent/AR083477A1/es active IP Right Grant
- 2011-10-19 NZ NZ610689A patent/NZ610689A/en not_active IP Right Cessation
- 2011-10-19 US US13/276,464 patent/US8552200B2/en not_active Expired - Fee Related
- 2011-10-19 ES ES11778520.4T patent/ES2678899T3/es active Active
- 2011-10-19 PE PE2013000887A patent/PE20140199A1/es not_active Application Discontinuation
-
2013
- 2013-04-15 IL IL225762A patent/IL225762A/en active IP Right Grant
- 2013-04-18 CL CL2013001073A patent/CL2013001073A1/es unknown
- 2013-04-22 CO CO13101928A patent/CO6690805A2/es unknown
- 2013-04-22 EC ECSP13012573 patent/ECSP13012573A/es unknown
Also Published As
Publication number | Publication date |
---|---|
ECSP13012573A (es) | 2013-07-31 |
EA022582B1 (ru) | 2016-01-29 |
KR101820645B1 (ko) | 2018-01-22 |
ES2678899T3 (es) | 2018-08-20 |
IL225762A0 (en) | 2013-06-27 |
CL2013001073A1 (es) | 2013-10-11 |
CA2815131C (en) | 2020-06-09 |
JP2014510696A (ja) | 2014-05-01 |
EA201300471A1 (ru) | 2014-01-30 |
MX2013004329A (es) | 2013-04-29 |
MX367623B (es) | 2019-08-29 |
NZ610689A (en) | 2014-08-29 |
NZ628871A (en) | 2015-07-31 |
US8552200B2 (en) | 2013-10-08 |
EP2630123A1 (en) | 2013-08-28 |
WO2012052167A1 (en) | 2012-04-26 |
CA2815131A1 (en) | 2012-04-26 |
KR20140001904A (ko) | 2014-01-07 |
EP3318556A1 (en) | 2018-05-09 |
AR083477A1 (es) | 2013-02-27 |
EP2630123B1 (en) | 2017-12-20 |
AU2011317855B2 (en) | 2015-04-30 |
CN103209962A (zh) | 2013-07-17 |
IL225762A (en) | 2017-06-29 |
BR112013010957A2 (pt) | 2016-08-30 |
AU2011317855A1 (en) | 2013-05-02 |
JP5947307B2 (ja) | 2016-07-06 |
CO6690805A2 (es) | 2013-06-17 |
CN103209962B (zh) | 2016-03-02 |
US20120101079A1 (en) | 2012-04-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PE20140199A1 (es) | 6-amino-nicotinamidas sustituidas como moduladores de kcnq2/3 | |
PE20131379A1 (es) | 2-oxi-quinolina-3-carboxamidas sustituidas como moduladores kcnq2/3 | |
PE20120780A1 (es) | Nicotinamida sustituida como moduladores kcnq2/3 | |
MX359882B (es) | Amidas como moduladores de canales de sodio. | |
MA32534B1 (fr) | Dérivés de cyclohexylamide et leur utilisation en tant qu'antagonistes des récepteurs de crf-1 | |
NZ710111A (en) | Quinoline and quinoxaline amides as modulators of sodium channels | |
PH12015501661A1 (en) | Pyridone amides as modulators of sodium channels | |
PE20120790A1 (es) | 2-mercaptoquinolin-3-carboxamidas sustituidas como moduladores de kcnq2/3 | |
PE20091842A1 (es) | Pirrolidinonas como activadores de glucoquinasa | |
PE20141682A1 (es) | Derivados de (4-fenilimidazol-2-il) etilamina utiles como moduladores de canal de sodio | |
GEP20146125B (en) | Aminopyrimidines as syk inhibitors | |
PE20121335A1 (es) | Compuestos derivados de amida como inhibidores de raf cinasas | |
CO6321273A2 (es) | N-fenil -y - lactamas subtituidas las cuales son agonistas ep2 para ser usados como agentes terapeuticos para el tratamiento de glaucoma, sindrome del intestino irritable y calvicie | |
PE20110150A1 (es) | Amidofenoxiindazoles como inhibidores de c-met | |
EA201500652A1 (ru) | Дифторметилникотиновые инданилкарбоксамиды | |
EA201390934A1 (ru) | Композиции и способы модулирования fxr | |
PE20160664A1 (es) | Compuestos heteroaromaticos y su uso como ligandos d1 de dopamina | |
EA201170051A1 (ru) | Гетероциклическое соединение и его применение | |
EA201300442A1 (ru) | ПИРРОЛИДИНОНЫ В КАЧЕСТВЕ ИНГИБИТОРОВ MetAP-2 | |
CO6341581A2 (es) | Derivados de heteroarilo como inhibidores de dgat1 | |
WO2015157559A3 (en) | 10',11'-modified saxitoxins useful for the treatment of pain | |
PE20150709A1 (es) | Benzamidas | |
CL2016000436A1 (es) | Método para el tratamiento de la enfermedad fibrótica | |
MX2011006006A (es) | Compuestos, composicion farmaceutica y metodos para utilizarse en el tratamiento de trastornos metabolicos. | |
MX2016008077A (es) | Compuestos heterociclicos fusionados como moduladores del canal ionico. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC | Refusal |